Apotex is a Canadian pharmaceutical corporation. Founded in 1974, the company is the largest producer of generic drugs in Canada, with sales exceeding one billion dollars (CAD) a year. The company produces more than 300 generic pharmaceuticals in approximately 4000 dosages, exporting to over 115 countries around the globe. The company has two main divisions: medical research and development; and biotechnology. The biotechnology division is divided into three subsidiaries.

PropertyValue
dbpedia-owl:Company/industry
dbpedia-owl:Company/product
dbpedia-owl:Organisation/foundationDate
  • 1974-01-01 00:00:00 (xsd:date)
dbpedia-owl:Organisation/keyPerson
dbpedia-owl:Organisation/keyPersonPosition
  • Dr. Bernard Sherman, CEO
  • Jack M. Kay, President
dbpedia-owl:Organisation/location
dbpedia-owl:Organisation/numberOfEmployees
  • 6500 (xsd:integer)
dbpedia-owl:Organisation/slogan
  • Advancing Generics
dbpedia-owl:Organisation/type
dbpedia-owl:foundationDate
  • 1974-01-01 00:00:00 (xsd:date)
dbpedia-owl:industry
dbpedia-owl:keyPerson
dbpedia-owl:keyPersonPosition
  • Dr. Bernard Sherman, CEO
  • Jack M. Kay, President
dbpedia-owl:location
dbpedia-owl:numberOfEmployees
  • 6500 (xsd:integer)
dbpedia-owl:product
dbpedia-owl:slogan
  • Advancing Generics
dbpedia-owl:type
dbpprop:abstract
  • Apotex is a Canadian pharmaceutical corporation. Founded in 1974, the company is the largest producer of generic drugs in Canada, with sales exceeding one billion dollars (CAD) a year. The company produces more than 300 generic pharmaceuticals in approximately 4000 dosages, exporting to over 115 countries around the globe. The company has two main divisions: medical research and development; and biotechnology. The biotechnology division is divided into three subsidiaries. Apotex owns 61% of Cangene Corp. , a Winnipeg-based biopharmaceutical company, according to Cangene's 2007 annual report. Cangene's business focuses are hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense against infectious diseases such as smallpox, hepatitis B and anthrax. Its products include WinRho SDF. Apotex has tied up with an Indian biopharmaceutical company, Intas Biopharmaceuticals, in April 2008 for developing generic version of blockbuster drug Filgrastim for US, Canadian and European market. In January 2004, ApoPharma was founded. Bernard (Barry) Sherman is the chairman and CEO and Jack M. Kay is the President.
dbpprop:companyLogo
dbpprop:companyName
  • Apotex, Inc.
dbpprop:companySlogan
  • Advancing Generics
dbpprop:companyType
dbpprop:foundation
  • 1974 (xsd:integer)
dbpprop:hasPhotoCollection
dbpprop:homepage
dbpprop:industry
dbpprop:keyPeople
dbpprop:location
dbpprop:numEmployees
  • 6500 (xsd:integer)
dbpprop:products
dbpprop:reference
dbpprop:wikiPageUsesTemplate
rdf:type
rdfs:comment
  • Apotex is a Canadian pharmaceutical corporation. Founded in 1974, the company is the largest producer of generic drugs in Canada, with sales exceeding one billion dollars (CAD) a year. The company produces more than 300 generic pharmaceuticals in approximately 4000 dosages, exporting to over 115 countries around the globe. The company has two main divisions: medical research and development; and biotechnology. The biotechnology division is divided into three subsidiaries.
rdfs:label
  • Apotex
owl:sameAs
skos:subject
foaf:homepage
foaf:name
  • Apotex, Inc.
foaf:page
is dbpprop:redirect of
is owl:sameAs of